When to include clinical study reports and regulatory documents in systematic reviews
Reporting bias is a major threat to the validity and credibility of systematic reviews. This article outlines the rationale for accessing clinical study reports and other regulatory documents (regulatory data) as a means of addressing reporting bias and identifies factors that may help decide whethe...
Principais autores: | Jefferson, T, Doshi, P, Boutron, I, Golder, S, Heneghan, C, Hodkinson, A, Jones, M, Lefebvre, C, Stewart, L |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BMJ Publishing Group
2018
|
Registros relacionados
-
The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors
por: Hodkinson, A, et al.
Publicado em: (2018) -
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
por: Jefferson, T, et al.
Publicado em: (2014) -
Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
por: Heneghan, C, et al.
Publicado em: (2014) -
Why reports of clinical trials should include updated meta-analyses
por: Heneghan, C, et al.
Publicado em: (2019) -
Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data
por: Heneghan, C, et al.
Publicado em: (2016)